The NEBA ADHD EEG is an innovative, FDA-approved test designed to aid in the diagnosis of ADHD by measuring brain wave patterns. This non-invasive test uses electroencephalography (EEG) to assess brain activity and helps identify specific markers that differentiate ADHD from other conditions. By analysing the ratio of theta and beta waves, NEBA offers a clearer understanding of how the brain functions in individuals with ADHD, making it a valuable diagnostic tool.
The Benefits of NEBA EEG in ADHD Diagnosis
Unlike traditional methods, the NEBA test directly measures brain wave patterns, revealing the neurological basis of ADHD symptoms such as inattention and impulsivity. The theta/beta ratio is typically higher in individuals with ADHD, indicating an imbalance in brain activity that contributes to difficulties in focus and regulation. This EEG-based approach provides objective data that can support ADHD diagnosis, particularly in cases where symptoms overlap with other conditions.
How It Helps in Treatment
By providing clearer insights into the brain’s electrical activity, NEBA EEG can help clinicians better understand the specific challenges an individual faces with ADHD. This enables a more personalised treatment approach, whether through medication or cognitive behavioural therapy (CBT), tailored to the patient’s unique brain activity. NEBA’s ability to identify specific brain wave patterns supports more effective therapeutic strategies.
Visit providers like ADHD Certify for personal consultations tailored to your ADHD care and support needs.
For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to ADHD fMRI tasks.
